{
  "primary": "PJA1",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "The E3 ubiquitin ligase PJA1 (also known as RNF127) promotes the degradation of ATXN3 through both the proteasome and autophagy, implying a direct regulatory interaction. [3]",
  "functions": [
    {
      "function": "ATXN3 Protein Stability",
      "arrow": "inhibits",
      "cellular_process": "PJA1 (Praja1), a RING-H2 finger E3 ubiquitin ligase, directly interacts with ATXN3. PJA1 then mediates the attachment of ubiquitin chains to ATXN3, targeting it for degradation by both the proteasome and the lysosome-autophagy pathway.",
      "effect_description": "PJA1 acts as a negative regulator of ATXN3 protein levels. By ubiquitinating ATXN3, PJA1 marks it for cellular clearance, thereby controlling its concentration. This mechanism is also effective for the polyQ-expanded, pathogenic form of ATXN3, suggesting that enhancing PJA1 activity could be a therapeutic strategy to reduce the toxic protein's aggregation in Spinocerebellar Ataxia Type 3 (SCA3).",
      "biological_consequence": [
        "PJA1 binds to ATXN3 → PJA1, as an E3 ligase, catalyzes the polyubiquitination of ATXN3 → Ubiquitinated ATXN3 is recognized by the proteasome and autophagy machinery → ATXN3 is degraded → Cellular levels of ATXN3 protein are reduced."
      ],
      "specific_effects": [
        "PJA1 directly interacts with and ubiquitinates both wild-type and polyQ-expanded ATXN3.",
        "PJA1-mediated ubiquitination targets ATXN3 for degradation via both the proteasome and lysosomal (autophagy) pathways.",
        "Overexpression of PJA1 enhances the degradation of ATXN3 and reduces the formation of toxic aggregates.",
        "Silencing of PJA1 leads to increased ATXN3 protein levels and diminished ubiquitination of ATXN3."
      ],
      "evidence": [
        {
          "paper_title": "Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity",
          "journal": "Cell Death & Disease",
          "year": 2021,
          "relevant_quote": "We report here that Praja1 (PJA1), a Ring-H2 ubiquitin ligase abundantly expressed in the brain... PJA1 interacts with polyQ proteins and enhances their degradation, resulting in reduced aggregate formation... we found enhanced ubiquitination of ataxin-3 in the presence of PJA1 but diminished ubiquitinated ataxin-3 when PJA1 was silenced, indicating PJA1’s ability to ubiquitinate polyQ proteins.",
          "pmid": "34161122"
        }
      ],
      "pmids": [
        "34161122"
      ],
      "interaction_effect": "inhibits",
      "interaction_direction": "primary_to_main",
      "function_effect": "inhibition"
    }
  ],
  "arrow": "inhibits",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input correctly identifies that PJA1 promotes ATXN3 degradation. The arrow direction in the input ('inhibits' from ATXN3 to PJA1) was incorrect. The corrected function describes the action of PJA1 *on* ATXN3, which is an inhibitory effect on ATXN3's stability and levels.",
  "mechanism": "PJA1 (Praja1), a RING-H2 finger E3 ubiquitin ligase, directly interacts with ATXN3. PJA1 then mediates the attachment of ubiquitin chains to ATXN3, targeting it for degradation by both the proteasome and the lysosome-autophagy pathway.",
  "effect": "PJA1 acts as a negative regulator of ATXN3 protein levels. By ubiquitinating ATXN3, PJA1 marks it for cellular clearance, thereby controlling its concentration. This mechanism is also effective for the polyQ-expanded, pathogenic form of ATXN3, suggesting that enhancing PJA1 activity could be a therapeutic strategy to reduce the toxic protein's aggregation in Spinocerebellar Ataxia Type 3 (SCA3).",
  "summary": "ATXN3 inhibits PJA1 to modulate regulation of atxn3 protein stability, ultimately affecting cellular levels of atxn3 protein are reduced.",
  "evidence": [
    {
      "paper_title": "Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity",
      "journal": "Cell Death & Disease",
      "year": 2021,
      "relevant_quote": "We report here that Praja1 (PJA1), a Ring-H2 ubiquitin ligase abundantly expressed in the brain... PJA1 interacts with polyQ proteins and enhances their degradation, resulting in reduced aggregate formation... we found enhanced ubiquitination of ataxin-3 in the presence of PJA1 but diminished ubiquitinated ataxin-3 when PJA1 was silenced, indicating PJA1’s ability to ubiquitinate polyQ proteins."
    }
  ],
  "interaction_effect": "inhibition",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 2
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--inhibits-- PJA1:",
  "protein_a": "ATXN3",
  "protein_b": "PJA1",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-24T04:11:50.044666Z",
  "last_updated": "2025-11-24T04:11:50.044666Z"
}